Clonality patterns of IGH and TCRB gene rearrangement across lymphoma and non-lymphoma: a pitfall in the interpretation of multiplex PCR
- 1Department of Pathology, Faculty of Medicine, Academic Research Division, University of Toyama, Toyama, Japan, Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan, Department of Hematology, Toyama University Hospital, Toyama, Japan
Abstract
Clonality testing using BIOMED-2-based multiplex PCR is widely applied in routine diagnostics, but its interpretation can be complicated by clonal-like peaks arising from non-neoplastic immune responses. In this study, we retrospectively analyzed routine diagnostic cases examined by IGH and TCRB multiplex PCR and assessed both the number of rearranged regions and peak patterns in B-cell lymphoma (N = 291), T-cell lymphoma (N = 48), Classic Hodgkin lymphoma (N = 31), reactive lymphoid hyperplasia (N = 28), and carcinoma (N = 41). The most clinically relevant finding was the frequent detection of apparent IGH clonality in carcinoma, often accompanied by polyclonal background. Clonal IGH peaks were detected in 16 of 35 carcinoma cases (46%), including 7 of 35 cases (20%) with peaks in two or more regions. Among these 16 cases, 11 (69%) showed polyclonal background. In contrast, reactive lymphoid hyperplasia showed much lower IGH positivity, with clonal peaks in 3 of 25 cases (12%) and only 1 of 25 cases (4%) with peaks in two or more regions. More informative than lineage-associated positivity itself were the disease-specific peak patterns, especially the frequent appearance of clonal-like IGH peaks with polyclonal background in carcinoma and the background-rich patterns seen in T-follicular helper cell lymphoma, angioimmunoblastic type/angioimmunoblastic T-cell lymphoma (AITL). These findings indicate that BIOMED-2 clonality assays capture not only neoplastic clones but also disease-specific immune background. Frequent IGH peaks with polyclonal background in carcinoma represent an important diagnostic pitfall and should be interpreted carefully together with the pathological and immunohistochemical results.
Related
- Cytologically Suggested Vulvar Involvement in a Dog with Multicentric Lymphoma After a Nodal Response to CHOP-Based Chemotherapy, with Discordant Clonality Results: A Case Report.
- Serum Free Light Chains in Lymphoma: A Phenotype-First Framework for Biological Interpretation, Analytical Control, and Clinical Use.
- CT-Referenced Diagnostic Performance and Complementary Error Patterns of Artificial Intelligence Versus a Single Emergency Physician in Chest Radiograph Interpretation: A Retrospective Paired Diagnostic Accuracy Study
- Clinical and Imaging Patterns of Neurological Involvement in Intravascular Large B-Cell Lymphoma: A Single-Center Retrospective Study †
- Real-World Treatment Patterns, Healthcare Resource Use, and Costs in Patients with Follicular Lymphoma, Waldenström Macroglobulinemia, and Marginal Zone Lymphoma: A Claims-Based Study in the USA
BibTeX
@article{fujikawa2026clonality,
title = {{Clonality patterns of IGH and TCRB gene rearrangement across lymphoma and non-lymphoma: a pitfall in the interpretation of multiplex PCR}},
author = {Miwa Fujikawa and Tomoko Miyata-Takata and Akihiro Kitadate and Noriko Okuno and Tomomi Kunisawa and Seiji Yamamoto and Shohei Kikuchi and Tsutomu Sato and Naoto Takahashi and Katsuyoshi Takata},
journal = {Journal of Clinical and Experimental Hematopathology : JCEH},
year = {2026},
month = sep,
doi = {10.3960/jslrt.26027},
url = {https://doi.org/10.3960/jslrt.26027},
note = {CC BY-NC-SA 4.0},
}
RIS
TY - JOUR
TI - Clonality patterns of IGH and TCRB gene rearrangement across lymphoma and non-lymphoma: a pitfall in the interpretation of multiplex PCR
AU - Miwa Fujikawa
AU - Tomoko Miyata-Takata
AU - Akihiro Kitadate
AU - Noriko Okuno
AU - Tomomi Kunisawa
AU - Seiji Yamamoto
AU - Shohei Kikuchi
AU - Tsutomu Sato
AU - Naoto Takahashi
AU - Katsuyoshi Takata
PY - 2026
DA - 2026/09/30
JO - Journal of Clinical and Experimental Hematopathology : JCEH
DO - 10.3960/jslrt.26027
UR - https://doi.org/10.3960/jslrt.26027
AB - Clonality testing using BIOMED-2-based multiplex PCR is widely applied in routine diagnostics, but its interpretation can be complicated by clonal-like peaks arising from non-neoplastic immune responses. In this study, we retrospectively analyzed routine diagnostic cases examined by IGH and TCRB multiplex PCR and assessed both the number of rearranged regions and peak patterns in B-cell lymphoma (N = 291), T-cell lymphoma (N = 48), Classic Hodgkin lymphoma (N = 31), reactive lymphoid hyperplasia (N = 28), and carcinoma (N = 41). The most clinically relevant finding was the frequent detection of apparent IGH clonality in carcinoma, often accompanied by polyclonal background. Clonal IGH peaks were detected in 16 of 35 carcinoma cases (46%), including 7 of 35 cases (20%) with peaks in two or more regions. Among these 16 cases, 11 (69%) showed polyclonal background. In contrast, reactive lymphoid hyperplasia showed much lower IGH positivity, with clonal peaks in 3 of 25 cases (12%) and only 1 of 25 cases (4%) with peaks in two or more regions. More informative than lineage-associated positivity itself were the disease-specific peak patterns, especially the frequent appearance of clonal-like IGH peaks with polyclonal background in carcinoma and the background-rich patterns seen in T-follicular helper cell lymphoma, angioimmunoblastic type/angioimmunoblastic T-cell lymphoma (AITL). These findings indicate that BIOMED-2 clonality assays capture not only neoplastic clones but also disease-specific immune background. Frequent IGH peaks with polyclonal background in carcinoma represent an important diagnostic pitfall and should be interpreted carefully together with the pathological and immunohistochemical results.
SN - 1346-4280
SN - 1880-9952
ER -